Forty-six (69.7%) CRC tissue specimens showed decreased relative SATB2 mRNA levels (tumor vs. matched non-involved colorectal mucosa), while 20 (30.3%) showed increased levels of SATB2 transcripts (Table 1, Figure 1A). The gene discussed is SATB2; the disease is colorectal carcinoma.